Liam Ratcliffe - Dec 14, 2021 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Liam Ratcliffe
Stock symbol
ARVN
Transactions as of
Dec 14, 2021
Transactions value $
-$23,833,381
Form type
4
Date filed
12/16/2021, 08:30 PM
Previous filing
Nov 15, 2021
Next filing
Jun 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale -$7.89M -119K -22.06% $66.01 422K Dec 14, 2021 See footnote F1, F2
transaction ARVN Common Stock Sale -$2.37M -36.3K -8.61% $65.38 386K Dec 14, 2021 See footnote F2, F3
transaction ARVN Common Stock Sale -$44.9K -700 -0.18% $64.20 385K Dec 14, 2021 See footnote F2, F4
transaction ARVN Common Stock Sale -$2.72M -40.3K -10.47% $67.46 345K Dec 15, 2021 See footnote F2, F5
transaction ARVN Common Stock Sale -$4.49M -67.5K -19.6% $66.50 277K Dec 15, 2021 See footnote F2, F6
transaction ARVN Common Stock Sale -$374K -5.7K -2.06% $65.74 271K Dec 15, 2021 See footnote F2, F7
transaction ARVN Common Stock Sale -$3.38M -48.5K -17.87% $69.66 223K Dec 16, 2021 See footnote F2, F8
transaction ARVN Common Stock Sale -$2.57M -37.2K -16.69% $68.97 186K Dec 16, 2021 See footnote F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.66 to $65.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
F2 The reported shares are held directly by AI Biotechnology LLC ("AIB"), a limited liability company of which the reporting person is the holder of units that are treated as profits interest units. The units owned by the reporting person do not convey a right to vote or dispose of the shares of the Issuer's Common Stock held by AIB. The reporting person disclaims beneficial ownership of all shares held by AIB and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.665 to $64.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.34 to $64.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.94 to $66.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5).
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.93 to $65.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6).
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.92 to $65.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7).
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.28 to $69.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (8).
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.275 to $68.335, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9).